Nitric oxide and mechanisms of redox signalling: matrix and matrix-metabolizing enzymes as prime nitric oxide targets.
One of the greatest biomedical breakthroughs of the twentieth century was the discovery of endothelium-derived relaxing factor and its identification as nitric oxide (NO). NO has received special attention ever since: besides its potent vasodilatory and vasoprotective effects, NO was identified as a key player in innate immunity and was found to act as an unconventional type of neurotransmitter. This article focuses on mechanisms of NO signalling that form the basis of functional cell responses to accommodate changes in the cellular microenvironment. Redox-based regulation of signal transduction and, on a more long-term scale, changes in gene expression will be exemplified by NO-modulation of matrix components and matrix-metabolizing enzymes. It seems to be a safe bet that ongoing analyses of NO signalling and gene expression will provide a wealth of promising therapeutic targets in human diseases.
Pfeilschifter
J
J
Pharmazentrum Frankfurt, Klinikum der Johann Wolfgang Goethe-Universität, Theodor-Stern-Kai 7, D-60590 Frankfurt am Main, Germany. Pfeilschifter@em.uni-frankfurt.de
Eberhardt
W
W
Huwiler
A
A
D000818:Animals; D005109:Extracellular Matrix / Q000201:enzymology* / Q000378:metabolism; D016326:Extracellular Matrix Proteins / Q000378:metabolism* / Q000502:physiology; D006801:Humans; D009569:Nitric Oxide / Q000378:metabolism* / Q000502:physiology; D010084:Oxidation-Reduction; D015398:Signal Transduction / Q000502:physiology*
D016326:Extracellular Matrix Proteins; D009569:Nitric Oxide